| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |